Home | Lymphoma Hub
Online lymphoma resource for healthcare professionals, providing information, news & support relating to lymphoma, Hodgkin & non Hodgkin disease
Related Articles
FDA Grants Orphan Drug Designation to ELC-100 in Pancreatic NETs
Investigators are assessing treatment with ELC-100 among patients with pancreatic neuroendocrine tumors as part of a phase 1/2 trial.
Histotripsy for liver cancer: What to know about this novel cancer treatment
Histotripsy is a new cancer treatment for tumors of the liver. But is it only for liver cancer? Whoâs a good candidate for it? Surgical…
Cytologic diagnosis of fumarate hydrataseâdeficient renal cell carcinoma: A singleâinstitutional experience
The authors conducted a retrospective review of clinical, cytomorphologic, histopathologic, immunohistochemical, and molecular analyses of cytology samples from patients who had fumarate hydratase-de…
SABCS24 ONCOALERT | ONCOBITES
In an interview, Dr. Agostinetto delves into the findings of Dr. Souza, who shares the results of his research explaining why larotrectinib is positioned as…
Durvalumab Shifts Decades Long SOC as First FDA-Approved Immunotherapy Regimen in LS-SCLC
Suresh Senan, MRCP, FRCR, PhD, details how the FDA approval of durvalumab has changed care for patients with limited-stage small cell lung cancer.
Post-ASH CLL highlights: BTK inhibitors & degraders, bispecific antibodies, & more!
VJHemOnc recently attended the 66th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego, CA, where we…
Fran Visco awarded the Presidential Citizens Medal: âWe are not going to change what we do or how we do it.â – The Cancer Letter
In 1992, 44-year old Philly trial lawyer and breast cancer survivor, Fran Visco, took the stand before the Senate Labor, HHS, Education Appropriations Subcommittee, asserting…
Molecular dynamics at immune synapse lipid rafts influence the cytolytic behavior of CAR T cells
CAR signaling domains determine molecular dynamics at the immune synapse and consequently influence CAR T cell killing behavior.
Melanoma Among Adult Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study
PURPOSEMelanoma as a subsequent malignant neoplasm has been described among childhood cancer survivors; however, the risk factors and long-term survival are not well understood.METHODSWe assessed…
The importance of shared decision making | Biomarker-driven management of NSCLC
Alexander Drilon and Alex Miles discuss the importance of shared decision making throughout the course of an NSCLC patientâs treatment.